Jrgensen L, Paludan-Mller AS, Laursen DRT, et al
BRIAN COURTNEY, RPLU AAIs Post With a growing list of available glucagon-like peptide-1 (#GLP1) drugs, it can be confusing to understand their differences
While nausea and GI disturbances can be uncomfortable, they aren't dangerous as long as they're not severe
Watch the full conversation on YouTube Listen now When I pushed Layne on what actually works long-term, he gave me a concrete list: they pick a sustainable plan they can still follow when life gets hard, they self-monitor by weighing in regularly as a feedback loop, they eat meals instead of snacking, they use some form of deliberate restraint like tracking macros or an eating window, and they exercise not to burn calories, but to stay sensitive to satiety signals
Maintenance frequency then varies based on individual response, age, and wellness objectives